4.44
-0.07 (-1.44%)
| Previous Close | 4.50 |
| Open | 4.55 |
| Volume | 221,250 |
| Avg. Volume (3M) | 2,867,217 |
| Market Cap | 1,540,940,672 |
| Price / Earnings (TTM) | 49.28 |
| Price / Earnings (Forward) | 9.43 |
| Price / Sales | 1.95 |
| Price / Book | 2.23 |
| 52 Weeks Range | |
| Earnings Date | 6 Nov 2025 |
| Profit Margin | 3.57% |
| Operating Margin (TTM) | 13.69% |
| Diluted EPS (TTM) | 0.070 |
| Quarterly Revenue Growth (YOY) | 2.60% |
| Quarterly Earnings Growth (YOY) | -88.60% |
| Total Debt/Equity (MRQ) | 82.71% |
| Current Ratio (MRQ) | 5.22 |
| Operating Cash Flow (TTM) | 150.72 M |
| Levered Free Cash Flow (TTM) | 74.77 M |
| Return on Assets (TTM) | 4.26% |
| Return on Equity (TTM) | 4.43% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bullish | Mixed |
| Health Information Services (Global) | Bullish | Mixed | |
| Stock | GoodRx Holdings, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | -2.0 |
| Insider Activity | -4.0 |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -2.10 |
|
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Core |
| % Held by Insiders | 12.51% |
| % Held by Institutions | 62.88% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Francisco Partners Management, Lp | 30 Jun 2025 | 60,078,184 |
| Lakewood Capital Management, Lp | 30 Jun 2025 | 4,157,274 |
| Petrus Trust Company, Lta | 30 Jun 2025 | 3,098,559 |
| Technology Crossover Management X, Ltd. | 30 Jun 2025 | 1,653,566 |
| Rip Road Capital Partners Lp | 30 Jun 2025 | 1,610,768 |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| NABIEY ROMIN | - | 4.12 | -4,449 | -18,330 |
| SPECTRUM EQUITY VII, L.P. | 4.28 | 4.14 | 0 | 4,484 |
| Aggregate Net Quantity | -4,449 | |||
| Aggregate Net Value ($) | -13,845 | |||
| Aggregate Avg. Buy ($) | 4.28 | |||
| Aggregate Avg. Sell ($) | 4.13 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| NABIEY ROMIN | Officer | 08 Sep 2025 | Disposed (-) | 4,449 | 4.12 | 18,330 |
| NABIEY ROMIN | Officer | 08 Sep 2025 | Option execute | 12,433 | - | - |
| SPECTRUM EQUITY VII, L.P. | 05 Sep 2025 | Sell (-) | 16,016 | 4.00 | 64,064 | |
| SPECTRUM EQUITY VII, L.P. | 04 Sep 2025 | Acquired (+) | 6,000,000 | 4.28 | 25,680,000 | |
| SPECTRUM EQUITY VII, L.P. | 04 Sep 2025 | Disposed (-) | 5,983,984 | 4.28 | 25,611,452 |
| Date | Type | Details |
|---|---|---|
| 02 Sep 2025 | Announcement | GoodRx Saddles Up With “The Savings Wrangler,” a Bold New Brand Campaign to Tame the Wild West of Prescription Pricing |
| 18 Aug 2025 | Announcement | GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic® and Wegovy® for $499-Per-Month |
| 06 Aug 2025 | Announcement | GoodRx Reports Second Quarter 2025 Results |
| 28 Jul 2025 | Announcement | GoodRx Appoints Amazon Pharmacy Veteran Laura Jensen as President of Pharma Solutions |
| 09 Jul 2025 | Announcement | GoodRx Announces Date for Second Quarter 2025 Earnings Release and Conference Call |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |